Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

You know you've said it. We all have. ''Mmm, that looks so delicious — I want to try some!'' That's because when it comes to what we eat, it's not just a matter of taste.